awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39277913-A83FDA1A-30D8-4880-87F1-7247088AC08B
Q39277913-A83FDA1A-30D8-4880-87F1-7247088AC08B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39277913-A83FDA1A-30D8-4880-87F1-7247088AC08B
Comparison of palbociclib in combination with letrozole or fulvestrant with endocrine therapies for advanced/metastatic breast cancer: network meta-analysis.
P2860
Q39277913-A83FDA1A-30D8-4880-87F1-7247088AC08B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39277913-A83FDA1A-30D8-4880-87F1-7247088AC08B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e5d17a7f6b4a78794bd19ca67ea145dfd37810f7
P2860
Letrozole, a new oral aromatase inhibitor: randomised trial comparing 2.5 mg daily, 0.5 mg daily and aminoglutethimide in postmenopausal women with advanced breast cancer. Letrozole International Trial Group (AR/BC3).